Inflarx Nv Stock Total Debt
| IFRX Stock | USD 1.15 0.08 6.50% |
InflaRx NV fundamentals help investors to digest information that contributes to InflaRx NV's financial success or failures. It also enables traders to predict the movement of InflaRx Stock. The fundamental analysis module provides a way to measure InflaRx NV's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to InflaRx NV stock.
Total Debt To Capitalization is likely to drop to 0.01 in 2025. InflaRx | Total Debt |
InflaRx NV Company Total Debt Analysis
InflaRx NV's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current InflaRx NV Total Debt | 1.12 M |
Most of InflaRx NV's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, InflaRx NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
InflaRx Total Debt Driver Correlations
Understanding the fundamental principles of building solid financial models for InflaRx NV is extremely important. It helps to project a fair market value of InflaRx Stock properly, considering its historical fundamentals such as Total Debt. Since InflaRx NV's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of InflaRx NV's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of InflaRx NV's interrelated accounts and indicators.
Click cells to compare fundamentals
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
InflaRx Short Long Term Debt Total
Short Long Term Debt Total |
|
Based on the latest financial disclosure, InflaRx NV has a Total Debt of 1.12 M. This is 99.96% lower than that of the Biotechnology sector and 99.66% lower than that of the Health Care industry. The total debt for all United States stocks is 99.98% higher than that of the company.
InflaRx Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses InflaRx NV's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of InflaRx NV could also be used in its relative valuation, which is a method of valuing InflaRx NV by comparing valuation metrics of similar companies.InflaRx NV is currently under evaluation in total debt category among its peers.
InflaRx NV Current Valuation Drivers
We derive many important indicators used in calculating different scores of InflaRx NV from analyzing InflaRx NV's financial statements. These drivers represent accounts that assess InflaRx NV's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of InflaRx NV's important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 111.4M | 174.3M | 128.0M | 81.0M | 93.2M | 88.5M | |
| Enterprise Value | 86.0M | 149.4M | 113.1M | 69.4M | 79.8M | 75.8M |
InflaRx NV Institutional Holders
Institutional Holdings refers to the ownership stake in InflaRx NV that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of InflaRx NV's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing InflaRx NV's value.| Shares | Ubs Group Ag | 2024-12-31 | 67.4 K | Citadel Advisors Llc | 2024-12-31 | 50.9 K | Birchview Capital, Lp | 2024-12-31 | 50 K | Geode Capital Management, Llc | 2024-12-31 | 48.1 K | Cubist Systematic Strategies, Llc | 2024-12-31 | 22.4 K | Susquehanna International Group, Llp | 2024-12-31 | 20.8 K | Walleye Trading Advisors, Llc | 2024-12-31 | 20.7 K | Pacifica Partners Inc | 2024-12-31 | 20.6 K | Bnp Paribas Arbitrage, Sa | 2024-12-31 | 20.3 K | Suvretta Capital Management, Llc | 2024-12-31 | 5.7 M | 683 Capital Management Llc | 2024-12-31 | 2.1 M |
InflaRx Fundamentals
| Return On Equity | -0.62 | ||||
| Return On Asset | -0.26 | ||||
| Operating Margin | (124.05) % | ||||
| Current Valuation | 17.45 M | ||||
| Shares Outstanding | 67.13 M | ||||
| Shares Owned By Insiders | 6.43 % | ||||
| Shares Owned By Institutions | 19.51 % | ||||
| Number Of Shares Shorted | 386.34 K | ||||
| Price To Earning | (7.90) X | ||||
| Price To Book | 1.12 X | ||||
| Price To Sales | 490.06 X | ||||
| Revenue | 63.09 K | ||||
| Gross Profit | (604.77 K) | ||||
| EBITDA | (42.06 M) | ||||
| Net Income | (42.67 M) | ||||
| Cash And Equivalents | 23.68 M | ||||
| Cash Per Share | 0.54 X | ||||
| Total Debt | 1.12 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 9.93 X | ||||
| Book Value Per Share | 1.11 X | ||||
| Cash Flow From Operations | (37.81 M) | ||||
| Short Ratio | 1.06 X | ||||
| Earnings Per Share | (1.06) X | ||||
| Target Price | 8.75 | ||||
| Number Of Employees | 62 | ||||
| Beta | 1.99 | ||||
| Market Capitalization | 82.57 M | ||||
| Total Asset | 120.21 M | ||||
| Retained Earnings | (286.13 M) | ||||
| Working Capital | 92.62 M | ||||
| Current Asset | 67.08 M | ||||
| Current Liabilities | 2.74 M | ||||
| Net Asset | 120.21 M |
About InflaRx NV Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze InflaRx NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of InflaRx NV using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of InflaRx NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for InflaRx Stock Analysis
When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.